Please note, this OEL/ADE monograph also applies to Psilocin (CAS RN 520-53-6), O-Acetylpsilocin (CAS RN 92292-84-7) and O-Acetylpsilocin fumarate (CAS RN 1217230-42-6). Psilocybin is a tryptamine psychedelic substance that occurs in the psilocybe mushroom. It has been used for centuries in religious ceremonies. Psilocybin is currently being evaluated in numerous clinical trials with a significant focus on major depressive disorder (MDD). Psilocybin is a Schedule I drug. This review could find no evidence of governmental approval for its use as a therapeutic agent at this time. Psilocybin is a 5HT2A agonist that acts similarly to lysergic acid diethylamide (LSD) and other serotonergic hallucinogens.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Psilocybin, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.